Recall Radar
All recallsMedicine & devices

Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR

Lack of Assurance of Sterility

Class II Medicine & devices FDA April 22, 2026
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
PAYLESS COMPOUNDERS, LLC — Beaverton, OR
Severity
Class II — moderate
Reported
April 22, 2026
Quantity
91 vials
Recall number
D-0471-2026
Status
Ongoing
Source
FDA

Where it went

OR

Other medicine & devices recalls

See every current recall on the live dashboard →